Key Takeaways
- • A Cayman Islands judge ruled Friday that Seth Harrison's Apple Tree Partners must immediately surrender control of a $2.5 billion bankrupt biotech venture capital fund backed by Russian billionaire Dmitry Rybolovlev's family trust.
- • Two Alvarez & Marsal employees have been appointed as court-appointed overseers of the fund, displacing the fund manager and marking a decisive victory for Rybolovlev's family trust in an escalating dispute.
- • The ruling represents the culmination of a lengthy legal battle between Rybolovlev's family trust and Apple Tree Partners, with the judge determining that management change was necessary for the fund's reorganization.
- • Oaktree Capital Management has been considering a $300 million investment in the bankrupt fund, adding institutional interest to a restructuring process now under court supervision.
Summary
Russian billionaire Dmitry Rybolovlev's family trust secured a decisive legal victory Friday in the Cayman Islands Grand Court, winning its fight to remove Seth Harrison's Apple Tree Partners as manager of a $2.5 billion bankrupt biotech venture capital fund. The judge's order mandates that Apple Tree Partners immediately relinquish control of the partnership, transferring operational oversight to two employees of restructuring firm Alvarez & Marsal, who will serve as court-appointed administrators during the fund's reorganization.
The ruling concludes a protracted dispute between Rybolovlev's investment entity and the New York-based biotech venture investor over governance and strategic direction of the fund. Apple Tree Partners, founded by biotech entrepreneur Seth Harrison, had previously defended its management position but faced sustained pressure from Rybolovlev's family trust, which sought removal of the fund manager as a condition for resolving the broader conflict. The judge determined that a change in management was necessary to facilitate the fund's Chapter 11 reorganization and protect investor interests.
The judicial intervention occurs as Oaktree Capital Management evaluates a potential $300 million investment in the distressed fund, suggesting institutional appetite for the biotech venture portfolio despite the governance turmoil. The appointment of external administrators under court authority provides a neutral management structure during this critical restructuring phase. The fund, which has invested billions in early-stage biotech companies, had faced the prospect of significant disruption to its portfolio companies due to the unresolved management dispute, making the judicial settlement a significant step toward stabilizing the vehicle and preserving value for remaining stakeholders.
The ruling concludes a protracted dispute between Rybolovlev's investment entity and the New York-based biotech venture investor over governance and strategic direction of the fund. Apple Tree Partners, founded by biotech entrepreneur Seth Harrison, had previously defended its management position but faced sustained pressure from Rybolovlev's family trust, which sought removal of the fund manager as a condition for resolving the broader conflict. The judge determined that a change in management was necessary to facilitate the fund's Chapter 11 reorganization and protect investor interests.
The judicial intervention occurs as Oaktree Capital Management evaluates a potential $300 million investment in the distressed fund, suggesting institutional appetite for the biotech venture portfolio despite the governance turmoil. The appointment of external administrators under court authority provides a neutral management structure during this critical restructuring phase. The fund, which has invested billions in early-stage biotech companies, had faced the prospect of significant disruption to its portfolio companies due to the unresolved management dispute, making the judicial settlement a significant step toward stabilizing the vehicle and preserving value for remaining stakeholders.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.